Previous 10 | Next 10 |
home / stock / cgn:cc / cgn:cc news
CognICA Chosen as Winner of Best AI Product in Healthcare Award at CogX Festival Vancouver, British Columbia--(Newsfile Corp. - September 13, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity") , a leading artificial intelligence (AI) hea...
CognICA Shortlisted for Most Innovative AI Product in Healthcare Award at CogX Festival Vancouver, British Columbia--(Newsfile Corp. - September 5, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity") , a leading artificial i...
Cognetivity's Landmark ADePT Study, Funded by the UK Innovation Agency and Published in Leading Neuroscience Journal Demonstrates Unprecedented Sensitivity in Detecting Cognitive Impairment in Early Stage Alzheimer's Disease, Essential for Treatment With New Drugs Vancouver, British Columbia--(N...
Approval opens up a new major market for CognICA, providing a solution to the urgent requirement for large-scale early detection and monitoring for the rollout of incoming Alzheimer's disease drugs Vancouver, British Columbia--(Newsfile Corp. - August 2, 2023) - Cognetivity Neurosciences Ltd....
Vital breakthrough for Alzheimer's patients worldwide with Eisai's Leqembi FDA approval; Cognetivity Neurosciences' AI CognICA technology poised to play pivotal role in early detection and monitoring globally Vancouver, British Columbia--(Newsfile Corp. - July 7, 2023) - Cognetivity Neuroscienc...
Partnership will accelerate adoption of Cognetivity's AI platform in Japan and other Asia-Pacific territories Vancouver, British Columbia--(Newsfile Corp. - June 13, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity") , is t...
US Medicare & Medicaid to require data collection as part of drug reimbursement Vancouver, British Columbia--(Newsfile Corp. - June 6, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE:1UB) ("the Company" or "Cognetivity") , a technology company that has cr...
Agreement aims at further development of Cognetivity's AI (Artificial Intelligence) platform through investigating comorbidities in diabetes and dementia Vancouver, British Columbia--(Newsfile Corp. - May 31, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (...
The news highlights the urgent need for more consistent, wide scale detection of the disease at an early stage Vancouver, British Columbia--(Newsfile Corp. - May 9, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity") i...
Company to provide its AI-powered cognitive assessment technology to policyholders in Japanese market to promote proactive approach to brain health Vancouver, British Columbia--(Newsfile Corp. - April 25, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ...
News, Short Squeeze, Breakout and More Instantly...
Cognetivity Neurosciences Ltd. Company Name:
CGN:CC Stock Symbol:
CNQC Market:
Cognetivity Neurosciences Ltd. Website:
Velan Inc. Subordinate Voting Shares (VLN:CA) is expected to report for Q1 2025 GoldMining Inc. (GOLD:CA) is expected to report $-0.02 for Q2 2024 Blue Star Gold Corp. (BAU:CA) is expected to report for Q2 2024 Organigram Holdings Inc. (OGI:CA) is expected to report $-0.07 for Q3 2024...
Richelieu Hardware Ltd. (RCH:CA) is expected to report $0.42 for Q2 2024 Goodfellow Inc. (GDL:CA) is expected to report for Q2 2024 Centamin plc Ordinary Shares (CEE:CA) is expected to report for Q1 2024 Velan Inc. Subordinate Voting Shares (VLN:CA) is expected to report for Q1 2025 ...
Canadian Investment Regulatory Organization Trading Halt - CGN Canada NewsWire VANCOUVER, BC , June 6, 2024 /CNW/ - The following issues have been halted by CIRO: Company: Cognetivity Neurosciences Ltd. CSE Symbol: CGN All Issues: Yes Reason: Cease Tr...